Cite

    Romero, J. et al. (2018). Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials. Europace. pp. f211-f216. [Online].